Form 8-K - Current report:
SEC Accession No. 0001564590-21-060502
Filing Date
2021-12-16
Accepted
2021-12-16 09:00:55
Documents
12
Period of Report
2021-12-13
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K NEW DIRECTOR ONETTO bolt-8k_20211213.htm   iXBRL 8-K 42683
  Complete submission text file 0001564590-21-060502.txt   171719

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA bolt-20211213.xsd EX-101.SCH 5665
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE bolt-20211213_lab.xml EX-101.LAB 19317
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bolt-20211213_pre.xml EX-101.PRE 11470
5 EXTRACTED XBRL INSTANCE DOCUMENT bolt-8k_20211213_htm.xml XML 3552
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 211496125
SIC: 2834 Pharmaceutical Preparations